| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
(5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine manufacturers
- GSK3i XIII
-
- $48.00
-
2026-08-08
- CAS:404828-08-6
- Purity: 99.46%
- Supply Ability: 10g
|
| | (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine Basic information |
| Product Name: | (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine | | Synonyms: | GSK-3 INHIBITOR XIII;4-Quinazolinamine, 5,6,7,8-tetrahydro-N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl-;GSK3i XIII;Glycogen synthase kinase 3,Glycogen synthase kinase-3,ATP-competitive,GSK3i XIII,Inhibitor,GSK-3 Inhibitor XIII,GSK-3i XIII,GSK-3,inhibit;N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl-5,6,7,8-tetrahydroquinazolin-4-amine;GSK3i XIII, 10 mM in DMSO;CAMK1D-IN-1;(5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine | | CAS: | 404828-08-6 | | MF: | C18H19N5 | | MW: | 305.38 | | EINECS: | | | Product Categories: | | | Mol File: | 404828-08-6.mol |  |
| | (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine Chemical Properties |
| Boiling point | 451.8±45.0 °C(Predicted) | | density | 1.262±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF:0.25(Max Conc. mg/mL);0.83(Max Conc. mM)
DMSO:0.15(Max Conc. mg/mL);0.5(Max Conc. mM) | | form | White crystalline solid. | | pka | 13.78±0.10(Predicted) | | color | white | | InChI | 1S/C18H15N5/c1-12-11-16(23-22-12)20-18-14-9-5-6-10-15(14)19-17(21-18)13-7-3-2-4-8-13/h2-11H,1H3,(H2,19,20,21,22,23) | | InChIKey | JYCUVOXSZBECAY-UHFFFAOYSA-N | | SMILES | [nH]1nc(cc1Nc2nc(nc4c2cccc4)c3ccccc3)C |
| WGK Germany | WGK 1 | | Storage Class | 11 - Combustible Solids |
| | (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine Usage And Synthesis |
| Uses | GSK-3 Inhibitor XIII is a potent and ATP-binding site inhibitor of GSK-3. | | Biological Activity | Cell permeable: no', 'Primary Target
GSK-3', 'Product does not compete with ATP.', 'Reversible: no', 'Target Ki: 24 nM against GSK-3 |
| | (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine Preparation Products And Raw materials |
|